pancreas. Inflammopharmacology 27:453-464, 2019. 27. Valenzuela R, Videla LA. Impact of the co- administration of n-3 fatty acids and olive oil components in preclinical nonalcoholic fatty liver disease models: a mechanistic view. Nutrients 12:499, 2020. 28. Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol 20:9330-9337, 2014. 29. Ruz M, Carrasco F, Rojas P, Basfi-Fer K, Hernández MC, Pérez A. Nutritional effects of zinc on metabolic syndrome and type 2 diabetes: mechanisms and main findings in human studies. Biol Trace Elem Res 188(1):177-188, 2019. 30. Norouzi S, Adulcikas J, Sohal SS, Myers S. Zinc stimulates glucose oxidation and glycemic control by modulating the insulin signaling pathway in human and mouse skeletal muscle cell lines. PLoS One 13(1):e0191727, 2018. 31. Martins de Albuquerque F, De Santis Filgueiras M, Pereira Rocha N, Pereira Castro AP, Cupertino Milagres L, Pessoa MC, et al. Associação das concentrações séricas de zinco com hipercolesterolemia e resistência à insulina em crianças brasileiras. Cad Sade Pblica 34(1):e00175016, 2018. 32. Ranasinghe P, Wathurapatha W, Ishara M, Jayawardana R, Galappatthy P, Katulanda P, et al. Effects of zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond) 12(1):26, 2015.
33. Marly Freitas de Carvalho L, Batista Beserra J, Sousa Carvalho L de, Batista Sousa C de, Rebêlo Sampaio Paz SM da, Melo dos Santos M. Association between magnesium, selenium and zinc consumption and lipid profile of Brazilian adolescents. Rev Chil Nutr 47(5):757-764, 2020. 34. Ranasinghe P, Wathurapatha WS, Galappatthy P, Katulanda P, Jayawardena R, Constantine GR. Zinc supplementation in prediabetes: a randomized double-blind placebo-controlled clinical trial. J Diabetes 10(5):386-397, 2018. 35. Uscátegui RM, Álvarez M, Laguado I, Soler W, Martínez, L, Arias R, et al. Factores de riesgo cardiovascular en ni os de 6 a 18 a os de Medellín (Colombia). An Pediatr 58(5):411-417, 2003. 36. Ripa S, Ripa R. Zinc y aterosclerosis. Minerva Med 5(12):647-654, 1994. 37. Foster M, Petocz P, Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis 210(2):344–352, 2010. 38. El Dib R, Gameiro O, Ogata M, Módolo N, Braz L, Jorge E, et al. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database Syst Rev 5:Cd005525, 2015. 39. Islam M, Attia J, Ali L, McEvoy M, Selim S, Sibbritt D, et al. Zinc supplementation for improving glucose handling in pre-diabetes: A double blind randomized placebo controlled pilot study. Diabetes Res Clin Pract 115:39-46, 2016.
87
Rev. Arg. de Lípidos - Vol. 6 (3) 2022
Powered by FlippingBook